FIELD: biochemistry; immunology.
SUBSTANCE: invention refers to biochemistry and immunology. Disclosed is an immunogenic composition for use as a vaccine for preventing a condition associated with S. pneumoniae, containing a glycoconjugate of isolated capsular polysaccharide S. pneumoniae serotype 22F with protein-carrier CRM197, and excipient.
EFFECT: invention can be used for vaccination of subjects against pneumococcal infections.
19 cl, 16 dwg, 20 ex, 25 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2778704C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND APPLICATION THEREOF | 2021 |
|
RU2774075C1 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULE SACCHARIDE ANTIGENS AND THEIR USE | 2015 |
|
RU2771293C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED ANTIGENS OF THE CAPSULAR SACCHARIDE, KITS CONTAINING THESE COMPOSITIONS AND USE THEREOF | 2016 |
|
RU2721128C2 |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
| METHODS OF GLYCOGONJUGATION AND COMPOSITION | 2013 |
|
RU2645071C2 |
| METHODS OF GLYCOCONJUGATION AND COMPOSITION | 2013 |
|
RU2724840C2 |
| INCREASE IN IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES | 2018 |
|
RU2774891C2 |
| GLYCOCONJUGATION PROCESS | 2013 |
|
RU2672053C2 |
